Pfizer/BioNTech vaccine effective against South African variant, study suggests

New strains of the virus that appeared in the UK and South Africa share the same N501Y mutation (Nick Potts/PA)

New strains of the virus that appeared in the UK and South Africa share the same N501Y mutation (Nick Potts/PA)

The Pfizer/BioNTech Covid-19 vaccine is effective against the coronavirus variant that emerged from South Africa, according to a new study.

In a study of 20 vaccine recipients, researchers at the University of Texas Medical Branch (UTMB) at Galveston, America, found that the vaccine neutralises the virus with the N501Y and E484K mutations.

You have reached your article limit. Already a subscriber? Sign in

BLACK FRIDAY

Offer ends in:

Days
0
Hours
0
Minutes
0
Seconds
0
Black Friday subscription offer

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited